SCHEMBL1090930

SCHEMBL1090930

COc1ccc(CC(=O)N2CCC(N3CCCCC(Nc4nccc(N5CCCCCC5)n4)C3)CC2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.48
NPSR1 Q6W5P4 1/20 0.48
HSD17B10 Q99714 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
ALK Q9UM73 2/20 0.46
CXCR4 P61073 1/20 0.45
ALDH1A1 P00352 3/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TSHR P16473 1/20 0.44
KMT2A Q03164 1/20 0.44
SLC2A1 P11166 1/20 0.44
HRH4 Q9H3N8 3/20 0.43
LMNA P02545 2/20 0.42
RAB9A P51151 1/20 0.42
ACACB O00763 1/20 0.42
GAA P10253 2/20 0.42
CCNC P24863 1/20 0.42
CDK8 P49336 1/20 0.42
MAPT P10636 1/20 0.42
EPHX2 P34913 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1091032 0.98 HPGD (0.48) HPGDNPSR1HSD17B10L3MBTL1ALK
SCHEMBL1090311 0.96 HPGD (0.49) HPGDNPSR1HSD17B10L3MBTL1ALK
SCHEMBL1091225 0.92 HPGD (0.47) HPGDNPSR1HSD17B10L3MBTL1ALK
SCHEMBL1089205 0.91 HPGD (0.48) HPGDNPSR1HSD17B10L3MBTL1ALK
SCHEMBL1090882 0.91 POLB (0.49) NPSR1ALKCXCR4KMT2AHRH4
SCHEMBL1090943 0.90 MRGPRX1 (0.49) ALKCXCR4ALDH1A1HRH4CCNK
SCHEMBL1090824 0.89 CXCR4 (0.58) CXCR4ALDH1A1HRH4ACACBCCNK
SCHEMBL1090900 0.89 POLB (0.51) NPSR1ALKCXCR4ALDH1A1TSHR
SCHEMBL1090345 0.88 HPGD (0.48) HPGDNPSR1HSD17B10L3MBTL1ALK
SCHEMBL1089481 0.88 MRGPRX1 (0.49) ALKCXCR4ALDH1A1HRH4CCNK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 HPGD 34/4885NPSR1 84/4885HSD17B10 1862/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 HPGD 34/4885NPSR1 84/4885HSD17B10 1862/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 HPGD 34/4885NPSR1 84/4885HSD17B10 1862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.